7-Epi Clindamycin Palmitate - Request Quote
7-Epi Clindamycin Palmitate
| SZ CAT No: | SZ-C076074 |
| CAS No | NA |
| Mol.F. | C34H63ClN2O6S |
| Mol.Wt. | 663.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
7-Epi Clindamycin Palmitate is chemically (2R,3R,4S,5R,6R)-6-((1S,2R)-2-Chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yl palmitate. 7-Epi Clindamycin Palmitate is supplied with detailed characterization data compliant with regulatory guideline. 7-Epi Clindamycin Palmitate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clindamycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality 7-Epi Clindamycin Palmitate
Purchase 7-Epi Clindamycin Palmitate
7-Epi Clindamycin Palmitate suppliers
7-Epi Clindamycin Palmitate manufacturers
7-Epi Clindamycin Palmitate price
Order 7-Epi Clindamycin Palmitate
Enquire 7-Epi Clindamycin Palmitate
7-Epi Clindamycin Palmitate cost
7-Epi Clindamycin Palmitate Supplier
7-Epi Clindamycin Palmitate Distributor
7-Epi Clindamycin Palmitate for Method Validation
Clindamycin Reference Standard
7-Epi Clindamycin Palmitate for ANDA Filing
7-Epi Clindamycin Palmitate for Forced Degradation Studies
7-Epi Clindamycin Palmitate Identification Standards
7-Epi Clindamycin Palmitate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


